05.06.2019 19:00:02

Medacta's MySpine MC Wins MedTech Breakthrough Award for Orthopaedics and Surgical Innovation


EQS Group-Media / 05.06.2019 / 19:00

Medacta's MySpine MC Wins MedTech Breakthrough Award for Orthopaedics and Surgical Innovation

-- MedTech Breakthrough Awards recognize game-changing technologies throughout the medical industry

-- MySpine MC named 2019's "Best Healthcare Navigation / Robotics Solution"

CASTEL SAN PIETRO, Switzerland - June 5, 2019 - Medacta International, an international company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques, today announced its MySpine Midline Cortical (MC) platform has been recognized as this year's "Best Healthcare Navigation / Robotics Solution" by MedTech Breakthrough. MySpine MC is Medacta's surgical technique for lumbar stabilization procedures based on 3D-printed, patient-matched guides that will help positioning vertebral screws in the midline cortical approach. Medacta's Midline Minimally Invasive Surgery (MIS) procedure provides high accuracy in screw positioning and robust posterior fixation through a minimally invasive, muscle sparing surgery. Short operating times, low per-case costs and a limited requirement for radiation exposure are further significant advantages of this technique.

"We are honored to have MySpine MC recognized by MedTech Breakthrough as one of this year's most innovative medical technologies," said Francesco Siccardi, CEO of Medacta International. "MySpine MC combines Medacta's expertise in 3D planning tools with its industry-leading patient-matched guides to create a seamless, start-to-finish platform perfect for orthopedic surgeons looking to enter the personalized spine surgery space in the outpatient or inpatient setting."

MySpine MC was selected from more than 3,500 nominations MedTech Breakthrough received this year across its range of categories. The awards are focused on bringing public recognition to innovations disrupting the international health and medical industry.

Surgeons utilizing the MySpine platform benefit from access to a user-friendly navigation system that provides guidance and tools for every stage of the personalized spinal surgery process. This includes a pre-operative planning web portal with a detailed 3D model of the patient, developed by Medacta's engineering team via a low-dose CT scan that limits radiation exposure. The anatomical insights identified foster a deep understanding of each patient case and create an opportunity for complete personalization, utilizing both surgeon preference and detailed patient modeling to plan implant sizing and trajectory. Based on this model, the MySpine system develops 3D-printed, patient-specific guides that provide high accuracy in screw positioning, creating the ideal surgical approach for a true minimally invasive procedure.

"I'm seamlessly involved in the pre-operative planning process when using the MySpine MC platform and its suite of technological tools," said Nima Salari, MD, Partner at Desert Institute for Spine Care in Phoenix. "The 3D planning tools mitigate surprises in surgery and allow me to be more confident going into the operating room, even with difficult approaches. This, alongside the patient-specific, 3D-printed guides, enables me to customize surgeries and accentuate my expertise as a personalized spinal surgeon to patients looking for a procedure completely catered to their specific anatomy."

For more information on the MySpine portfolio, visit www.medacta.com/EN/myspine.

About Medacta International
Medacta is an international orthopaedics company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta's products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of the minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery ("AMIS") technique for hip replacements. Medacta has leveraged its orthopedic expertise and comprehensive understanding of the human body to develop the sophisticated "MySolutions" technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures. Medacta is headquartered in Castel San Pietro, Switzerland, and Rancate, Switzerland, and employs approximately 970 people. To learn more about Medacta, please visit www.medacta.com and follow @Medacta on Twitter and LinkedIn.

# # #



Issuer: Medacta Group SA
Key word(s): Research/Technology

End of Corporate News


820213  05.06.2019 

fncls.ssp?fn=show_t_gif&application_id=820213&application_name=news&site_id=smarthouse

Analysen zu Medactamehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Medacta 78,60 2,12% Medacta